T
AVNS

Tidemark’s Avanos Medical AVNS Stock Holding History

Tidemark’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$238 Hold
17
– – ﹤0.01% 847
2025
Q4 		$191 Hold
17
– – ﹤0.01% 639
2025
Q3 		$197 Hold
17
– – ﹤0.01% 669
2025
Q2 		$208 Sell
17
-11
-39% -$138 ﹤0.01% 689
2025
Q1 		$402 Buy
+28
New +$437 ﹤0.01% 680
2024
Q4 		– Sell
-28
Closed -$673 – 628
2024
Q3 		$673 Sell
28
-3
-10% -$69 ﹤0.01% 587
2024
Q2 		$617 Hold
31
– – ﹤0.01% 582
2024
Q1 		$617 Buy
+31
New +$599 ﹤0.01% 659

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Tidemark's AVNS Position: Q1 2026 in Review

Tidemark held its Avanos Medical (AVNS) position steady in Q1 2026 at 17 shares worth $238. The position accounts for ﹤0.01% of the portfolio, ranked #847.

Tidemark first reported a position in AVNS in Q1 2024 and has held it in 8 quarters since. The position peaked at $673 in Q3 2024. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Tidemark held 17 shares of Avanos Medical worth $238 as of Q1 2026.
  • Tidemark left its Avanos Medical share count unchanged in Q1 2026.
  • Avanos Medical made up ﹤0.01% of Tidemark's portfolio in Q1 2026, its #847 holding.
  • Tidemark first reported a position in Avanos Medical in Q1 2024 and has held it in 8 quarters since.
  • Tidemark's Avanos Medical position peaked at $673 in Q3 2024.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Tidemark's 13F filing for Q1 2026, filed 7 May 2026.